ANTIBODY ENGINEERING Fine-tuning antibody-drug conjugates

被引：13
|
作者：
Flemming, Alexandra
机构：
来源：
NATURE REVIEWS DRUG DISCOVERY | 2014年 / 13卷 / 03期
关键词：
D O I：
10.1038/nrd4266
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：178 / 178
页数：1
相关论文
共 50 条
  • [31] Antibody-drug conjugates in indolent lymphoma
    Viardot, A.
    Oncology Research and Treatment, 2015, 38 : 87 - 87
  • [32] Antibody-Drug Conjugates in Urothelial Carcinomas
    Sarfaty, Michal
    Rosenberg, Jonathan E.
    CURRENT ONCOLOGY REPORTS, 2020, 22 (02)
  • [33] Antibody-Drug Conjugates for Breast Cancer
    Marme, Frederik
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (1-2) : 26 - 36
  • [34] Antibody-Drug Conjugates for Cancer Treatment
    Lambert, John M.
    Berkenblit, Anna
    ANNUAL REVIEW OF MEDICINE, VOL 69, 2018, 69 : 191 - 207
  • [35] DAR Analysis of Antibody-Drug Conjugates
    不详
    LC GC EUROPE, 2017, 30 (03) : 170 - 170
  • [36] Development of novel antibody-drug conjugates
    Takahashi, Shunji
    CANCER SCIENCE, 2021, 112 : 1026 - 1026
  • [37] Antibody-drug conjugates for multiple myeloma
    McMillan, Annabel
    Warcel, Dana
    Popat, Rakesh
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (07) : 889 - 901
  • [38] Antibody-Drug Conjugates for Cancer Therapy
    Hafeez, Umbreen
    Parakh, Sagun
    Gan, Hui K.
    Scott, Andrew M.
    MOLECULES, 2020, 25 (20):
  • [39] Antibody-drug conjugates in tumor therapy
    Sammet, Benedikt
    Steinkhler, Christian
    Sewald, Norbert
    PHARMACEUTICAL PATENT ANALYST, 2012, 1 (01) : 65 - 73
  • [40] Antibody-drug conjugates in breast cancer
    Zhu, Yinxing
    Song, Yaqi
    Zhou, Xilei
    Zhang, Wenwen
    Luo, Honglei
    CARCINOGENESIS, 2025, 46 (01)
12345